abooyaser
عضو محترف - مشرف القسم السعودي
- التسجيل
- 24 مايو 2004
- المشاركات
- 3,425
Company Name: Neostem Inc
Company Description: Neostem Inc Neostem, Inc. engages in the collection, processing, and storage of adult stem cells for autologous use in the United States. Its stem cell-banking process primarily involves in the mobilization, cell collection, cell processing, and cryopreservation. The company provides adult stem cells for autologous use in the treatment of cardiac disease, degenerative, autoimmune, neurological, and age-related musculoskeletal disorders, as well as diabetes, breast cancer, and wound healing. It has a strategic alliance with UTEK Corporation. The company was founded in 2002. It was formerly known as Corniche Group Incorporated and changed its name to Phase III Medical, Inc. in 2003. Further, it changed its name to Neostem, Inc. in 2006. Neostem is headquartered in New York, New York
Web Site: http://www.neostem.com
Company Description: Neostem Inc Neostem, Inc. engages in the collection, processing, and storage of adult stem cells for autologous use in the United States. Its stem cell-banking process primarily involves in the mobilization, cell collection, cell processing, and cryopreservation. The company provides adult stem cells for autologous use in the treatment of cardiac disease, degenerative, autoimmune, neurological, and age-related musculoskeletal disorders, as well as diabetes, breast cancer, and wound healing. It has a strategic alliance with UTEK Corporation. The company was founded in 2002. It was formerly known as Corniche Group Incorporated and changed its name to Phase III Medical, Inc. in 2003. Further, it changed its name to Neostem, Inc. in 2006. Neostem is headquartered in New York, New York
Web Site: http://www.neostem.com
مقال عنها في مجلة businessweek
A Stem-Cell Bank Is Drawing Interest
The idea of using adults' own stem cells to treat diseases, such as leukemia, is drawing investors' attention. They're looking at NeoStem (NBS ), a tiny outfit that specializes in collecting, processing, and storing stem cells from healthy adults for their personal medical use. It has applied for a patent on its technology using adult cells to treat specific ailments. "NeoStem has innovative technology whose value will surely be enhanced as new applications for stem cell therapies continue to emerge," says John Pappajohn, president of Equity Dynamics, which owns shares. Its stock, now at 5.00, started trading on the American Stock Exchange on Aug. 9 at 5.15 a share after a 1-for-10 reverse split. Walter Prendergast of Paradigm Capital Management, which owns shares, says stem cells represent one of the most exciting areas for investors. "They can influence how diseases are treated," he says. With its processing and storage lab in California and collection facilities using NeoStem's technology in four major cities, "we are well positioned for growth," says CEO Robin Smith. Some investors see the stock hitting 9 in a year
سهم طبي لشركه تحتوي علي بنك للخلايا يتبرع بها البالغ ويستعين بها مستقبلا في علاج الأمراض المستعصيه مثل مرض السكر وغيره
المشكله ان الشركه مررررررت بعدة تقسيمات عكسيه وحاليا مسجله في amex ب 5 $ واقفال امس علي 5.15 واعلي سعر 5.20
السهم مجتاز الفلترررر ومستقبله واعد -- علي رابط الشركه فيلم عن الفكرة الطبيه في استخدام الخلايا البشريه لنفس البشر لعلاج الأمراض المستعصيه --- التشارت فيما بعد
مطلوب اراء الأعضاء في هذا الموضوع من جميع النواحي ---- لو تكرمتم
سلالالالالالالالالالالالام
